Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Congenital disorder of glycosylation type I · Disorder of protein N-glycosylation
ALG1-congenital disorder of glycosylation
A severe form of congenital disorders of N-linked glycosylation characterized by severe developmental and psychomotor delay, muscular hypotonia, intractable early-onset seizures, and microcephaly. Additional features include altered blood coagulation with a high probability of hemorrhages or thromboses, nephrotic syndrome, ascites, hepatomegaly, cardiomyopathy, ocular manifestations (strabismus, nystagmus), and immunodeficiency. The disease is caused by loss-of-function mutations in the gene ALG1 (16p13.3).
This condition has no sub-types.